A fight over an embattled drug discount program is intensifying on Capitol Hill, as lawmakers weigh competing proposals to reshape the program amid escalating tensions between hospitals and drugmakers.
Lawmakers in both chambers have rolled out, or are planning to soon introduce, fresh proposals to alter the 340B program, which requires drug manufacturers sell deeply discounted drugs to safety net providers, including some hospitals and community health centers that serve large numbers of low-income patients.
